Cargando…
Eligibility criteria to cisplatin in head and neck squamous cell carcinoma: Egyptian expert opinion
INTRODUCTION: The use of cisplatin in clinical practice in the management of head and neck squamous cell carcinoma (HNSCC) is limited by its toxicity and acquired resistance, which makes the decision‐making process of its prescription multifactorial. METHODS: An Egyptian expert panel (comprising nin...
Autores principales: | Abdulla, Mohamed, Belal, Abdel Aziz, Sakr, Amr, El Arab, Lobna E., Mokhtar, Mohsen, Allahloubi, Nasr, Ghali, Ramy, Hashem, Tarek, Arafat, Waleed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847398/ https://www.ncbi.nlm.nih.gov/pubmed/36698712 http://dx.doi.org/10.1002/hsr2.1037 |
Ejemplares similares
-
The Chinese Expert Consensus on Evaluation of Coma after Cardiopulmonary Resuscitation
Publicado: (2016) -
The Experts Consensus for Patient Management of Neurosurgical Critical Care Unit in China (2015)
Publicado: (2015) -
ASCCP Committee Opinion: Adjuvant Human Papillomavirus Vaccine for Patients Undergoing Treatment for Cervical Intraepithelial Neoplasia
por: Sharpless, Kathryn E., et al.
Publicado: (2023) -
Consensus by Chinese Expert Panel on Chlamydia trachomatis-Resistant and Chlamydia trachomatis-Persistent Infection
por: Qi, Man-Li, et al.
Publicado: (2017) -
UK’s initial operational response and specialist operational response to CBRN and HazMat incidents: a primer on decontamination protocols for healthcare professionals
por: Chilcott, Robert P, et al.
Publicado: (2019)